miRNA-146a in Rheumatoid Arthritis: A New Therapeutic Strategy

Immunotherapy - United Kingdom
doi 10.2217/imt.11.70
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Medicine Ltd

Related search

MicroRNA-146a Expresses in Interleukin-17 Producing T Cells in Rheumatoid Arthritis Patients

BMC Musculoskeletal Disorders
RheumatologyOrthopedicsSports Medicine
2010English

Progranulin: A Promising Therapeutic Target for Rheumatoid Arthritis

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2011English

Etanercept: Therapeutic Use in Patients With Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1999English

P100 Systemic and Local IL-17A and miR-146A Levels in Rheumatoid Arthritis Patients

2019English

Rheumatoid Arthritis as a Therapeutic Challenge in a Patient With Lynch Syndrome

American Journal of Case Reports
Medicine
2015English

IL-17/TNF-α BISPECIFIC ANTIBODIES AS NEW THERAPEUTIC APPROACH TO RHEUMATOID ARTHRITIS

TURKISH MEDICAL STUDENT JOURNAL
2020English

PTPN22 Splice Forms: A New Role in Rheumatoid Arthritis

Genome Medicine
Molecular MedicineGeneticsMolecular Biology
2012English

P062 Histone Deacetylase 1 (HDAC1): A Novel Therapeutic Target in Rheumatoid Arthritis

2019English

MicroRNAs as New Player in Rheumatoid Arthritis

Joint Bone Spine
Rheumatology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy